This inventor holds 1 USPTO granted patent. Top assignees: Ruse Technologies, LLC, The UAB Research Foundation (The University of Alabama at Birmingham). Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2011
Title: Greg Ruse: Innovator in Atrial Fibrillation Treatment
Introduction
Greg Ruse is a notable inventor based in Clermont, FL (US), recognized for his contributions to medical technology. He holds a patent for an innovative apparatus designed to treat atrial fibrillation and atrial tachycardia. His work has the potential to significantly improve patient outcomes in the field of cardiology.
Latest Patents
Greg Ruse's patent, titled "Apparatus and method for treating atrial fibrillation and atrial tachycardia," presents a groundbreaking approach to managing these conditions. The apparatus features means for dynamically steering or selecting two or more current vector paths, either sequentially or simultaneously, for defibrillation. This technology aims to alter the transmembrane potential in the left and right atria, effectively halting atrial fibrillation or atrial tachycardia in patients. He has been granted 1 patent for this significant invention.
Career Highlights
Throughout his career, Greg Ruse has been associated with several organizations that focus on technological advancements in healthcare. He has worked with Ruse Technologies, LLC, and the UAB Research Foundation, contributing his expertise to the development of innovative medical solutions.
Collaborations
Greg has collaborated with notable professionals in his field, including Raymond E. Ideker and Derek J. Dosdall. These partnerships have further enhanced his research and development efforts in medical technology.
Conclusion
Greg Ruse's innovative work in treating atrial fibrillation and atrial tachycardia showcases his commitment to improving patient care through technology. His contributions to the medical field are significant and continue to pave the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile